48 results on '"Al-Hakim, Ali"'
Search Results
2. Characterization of currently marketed heparin products: Key tests for LMWH quality assurance
3. Characterization of currently marketed heparin products: Analysis of heparin digests by RPIP-UHPLC–QTOF-MS
4. Combining 1H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants
5. Diversifying the global heparin supply chain: reintroduction of bovine heparin in the United States? The global supply chain for bovine and porcine heparin and regulatory considerations are examined
6. USP compendial methods for analysis of heparin: chromatographic determination of molecular weight distributions for heparin sodium
7. Biocatalysts for the Synthesis and Modification of Biopolymers
8. Acidic Polysaccharides: Their Modification and Potential Uses
9. Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns
10. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data
11. Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their 1H NMR spectra
12. Characterization of currently marketed heparin products: key tests for quality assurance
13. Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests
14. Contaminated Heparin associated with adverse clinical events and activation of the contact system
15. Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug Applications
16. General Considerations for Diversifying Heparin Drug Products by Improving the Current Heparin Manufacturing Process and Reintroducing Bovine Sourced Heparin to the US Market
17. Late recurrence of an ovarian yolk sac tumour as a carcinosarcoma
18. Secondary Aorto-jejunal fistula
19. أثر انتوظ فَ انبشر نلإدارة الإنكترون تَ ف ع هً بَث إدارة ان عًرفت ف انجبيعبث انفهسط نَ تَ-دراست تطب قَ تَ عهي جبيعت الاقصي-غسة-فهسط نَ
20. USP compendial methods for analysis of heparin: chromatographic determination of molecular weight distributions for heparin sodium
21. The US regulatory and pharmacopeia response to the global heparin contamination crisis
22. Comparative Study of Visual Cues in Iranian Gabbeh and Paul Klee's Paintings: A Comparative Approach (Case Study of Colour and Geometric Shapes).
23. FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia
24. FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer
25. FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer
26. Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary
27. Characterization of currently marketed heparin products: composition analysis by 2D-NMR
28. Class Modeling Analysis of Heparin 1H NMR Spectral Data Using the Soft Independent Modeling of Class Analogy and Unequal Class Modeling Techniques
29. Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their 1H NMR spectra
30. Characterization of currently marketed heparin products: key tests for quality assurance
31. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
32. Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.
33. Class Modeling Analysis of Heparin 1H NMR Spectral Data Using the Soft Independent Modeling of Class Analogy and Unequal Class Modeling Techniques.
34. Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their H NMR spectra.
35. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities
36. A new method for sequencing linear oligosaccharides on gels using charged, fluorescent conjugates
37. Oligosaccharide mapping of low-molecular-weight heparins: structure and activity differences
38. Isolation and recovery of acidic oligosaccharides from polyacrylamide gels by semi-dry electrotransfer
39. IRAQ: TELECOM MINISTRY PROJECT TO DEVELOP TELEPHONE SYSTEM
40. Studies towards the development of chemically synthesized non-radioactive biotinylated nucleic acid hybridization probes.
41. Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?
42. A Wittig reaction on mucochloric and mucobromic acids. Preparation of ethyl (2, 4 -4,5-dihalo-2,4-pentadienoates and alkyl 2 -5-bromo-2-penten-4-ynoates
43. Synthesis of 1,2-O-Isopropylidene-L-threitol and its Conversion to (R)-1,2-O-Isopropylideneglycerol
44. Studies towards the synthesis of analogues of l-ascorbic acid
45. Nucleic acid hybridization in plant virus diagnosis and characterization
46. A Wittig reaction on mucochloric and mucobromic acids. Preparation of ethyl (2 [formula omitted], 4 [formula omitted] -4,5-dihalo-2,4-pentadienoates and alkyl 2 [formula omitted] -5-bromo-2-penten-4-ynoates
47. Combining 1H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants
48. Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.